PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

Clinical trial NCT00829829 · COMPLETED

Trial details

NCT number: NCT00829829
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Intercritical Gout

Start date: 2009-02-01
Primary completion: 2010-05-01
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.